Tazret 0.05% Gel

Tazret Gel (Tazarotene 0.05%)

Tazret Gel is a high-potency dermatological intervention containing Tazarotene, a third-generation receptor-selective retinoid specifically engineered for the clinical management of plaque psoriasis and acne vulgaris. Utilizing a unique “Keratolytic-Modulation” delivery system, this formulation works by concurrently modulating the organized expression of retinoid-responsive genes and reinforcing the structural integrity of the skin barrier. By neutralizing the biochemical triggers of hyperproliferation and facilitating the organized reduction of localized inflammatory markers, Tazret effectively promotes a significant decrease in lesional thickness and a reduction in metabolic dullness. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the epidermal matrix while promoting a stable, physiological recovery from keratinization stressors.

Key Features

• Specifically formulated with Tazarotene to target the primary pathways of RAR-beta and RAR-gamma receptors.
• Clinically recognized for its role in facilitating the natural optimization of cellular differentiation and desquamation.
• Specifically engineered to reach therapeutic levels within the follicular and epidermal layers, ensuring a robust defense against comedogenesis.
• Acts as a functional catalyst to stabilize the skin surface and support the reduction of localized plaque elevation.
• Formulated to address epidermal fatigue caused by various physiological and environmental stress factors through a controlled-release gel.

Key Ingredients

• Tazarotene (0.05% or 0.1% w/w)
• Benzyl Alcohol
• Carbomer 934P
• Hexylene Glycol
• Purified Water Base

Precautions

• This is a high-potency dermatological health intervention. Consult with a specialist prior to use to ensure a formal clinical diagnosis of psoriasis or acne.
• Strictly contraindicated for use during pregnancy. A negative pregnancy test is recommended prior to administration, and effective contraception must be maintained.
• Tazarotene increases vulnerability to solar radiation; the daily application of a high-SPF, broad-spectrum sunscreen and protective clothing is mandatory.
• Do not apply to broken, eczematous, or sunburned skin. Avoid contact with the eyes, eyelids, and internal mucosal surfaces.
• Discontinue use immediately if persistent severe redness, intense burning, or localized edema occurs during the initial treatment phase.
• Keep the tube tightly closed and store in a cool, dry place (below 25°C). Protect from direct light to maintain the molecular stability of the active constituents.

How to Use

• Thoroughly cleanse the affected area with a mild, non-medicated cleanser and ensure the skin is completely dry before application.
• Apply a pea-sized amount of the gel, ensuring a uniform, thin layer is established only over the affected lesional areas.
• For optimal clinical results, administration should occur once daily, preferably in the evening, as part of your primary skin restoration regimen.
• Gently massage the gel into the skin until it is no longer visible. Wash hands thoroughly with soap and water after administration to prevent accidental transfer.
• Use as a standalone treatment. If utilizing moisturizers, ensure the gel has fully penetrated the tissues for at least 1 hour before applying secondary dermal products.
• Maintain a regular application schedule for at least 8 to 12 weeks to document visible improvements in epidermal clarity and the restoration of skin health.

Legal Disclaimer: Tazret Gel is a specialized pharmacological product. Individual results vary based on the patient’s baseline skin state and physiological response. This product is for use under professional guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.